Kent Hawryluk

Biography

 Mr. Hawryluk has served as a member of board of directors since February 2015. He serves as Co-Founder/Chief Business Officer of Avidity NanoMedicines which is a pioneer in precision nanomedicines and also Co-Founder/CEO of MB2 which is a clinical development stage company focused on diabetes and obesity. Previously, Mr. Hawryluk was Co-Founder/Chief Business Officer of Marcadia Biotech, which was acquired by Roche. He also currently serves as partner of Twilight Venture Partners, a private seed- and early-stage life science venture fund. He was a founding partner of JEGI Capital, a venture capital fund co-sponsored by GE Capital that launched in 2000. Mr. Hawryluk holds a Bachelor’s degree from Princeton University, an MBA from Kellogg School of Management at Northwestern University, and a M.Sc. in Biology from Indiana University-Purdue University Indianapolis.

Research Interest

 NanoMedicines,clinical development